Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Pruritus of Cholestasis
NCT00058890Phase 3
Key facts
- Status
- Completed
- Start
- Nov 2000
- Primary completion
- Jan 2004
- Countries
- 1
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Modality
- Small Molecules
- Drugs
- gabapentin
- Conditions
- pruritus
01
Overview
Phase 3, randomised, double-blind trial of gabapentin in pruritus, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Change in scratching activity monitoring system at 4 weeks. Started Nov 2000; status: completed.
02
Design
- Study design
- RandomizedDouble-blind
03
Endpoints
Primary
Change in scratching activity monitoring system
Secondary
Change in visual analogue scale for pruritus
Beyond the preview
Go deeper on NCT00058890.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058890.